Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Kirk

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Urology|April 23, 2018
The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder MedicationsParth K Modi, Ye Wang, Peter S Kirk, et al.
Neurourology and Urodynamics|March 23, 2018
The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndromePeter S Kirk, Yahir Santiago-Lastra, Yongmei Qin, et al.
International Journal of Molecular Sciences|May 24, 2013
Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bonePeter S Kirk, Theodore Koreckij, Holly M Nguyen, et al.
Urology|February 7, 2017
Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel DiseasePeter S Kirk, Shail Govani, Tudor Borza, et al.
Urology Practice|May 5, 2023
Naloxegol versus Alvimopan for Enhancing Postoperative Recovery following Radical Cystectomy for Bladder CancerPeter S Kirk, Austin Wang, Dima Raskolnikov, et al.
The Journal of Surgical Research|May 21, 2015
One-year postoperative resource utilization in sarcopenic patientsPeter S Kirk, Jeffrey F Friedman, David C Cron, et al.
American Journal of Surgery|January 22, 2017
Predictors of operative failure in parathyroidectomy for primary hyperparathyroidismDavid C Cron, Steven R Kapeles, Elizabeth A Andraska, et al.
Urology Practice|December 18, 2018
Potential Savings in Medicare Part D for Common Urological ConditionsPeter S Kirk, Tudor Borza, James M Dupree, et al.
BJU International|September 25, 2018
Characterising potential bone scan overuse amongst men treated with radical prostatectomyPeter S Kirk, Tudor Borza, Megan E V Caram, et al.
BJU International|July 18, 2019
Characterising 'bounce-back' readmissions after radical cystectomyPeter S Kirk, Ted A Skolarus, Bruce L Jacobs, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Urology|April 23, 2018
The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder MedicationsParth K Modi, Ye Wang, Peter S Kirk, et al.
Neurourology and Urodynamics|March 23, 2018
The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndromePeter S Kirk, Yahir Santiago-Lastra, Yongmei Qin, et al.
International Journal of Molecular Sciences|May 24, 2013
Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bonePeter S Kirk, Theodore Koreckij, Holly M Nguyen, et al.
Urology|February 7, 2017
Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel DiseasePeter S Kirk, Shail Govani, Tudor Borza, et al.
Urology Practice|May 5, 2023
Naloxegol versus Alvimopan for Enhancing Postoperative Recovery following Radical Cystectomy for Bladder CancerPeter S Kirk, Austin Wang, Dima Raskolnikov, et al.
The Journal of Surgical Research|May 21, 2015
One-year postoperative resource utilization in sarcopenic patientsPeter S Kirk, Jeffrey F Friedman, David C Cron, et al.
American Journal of Surgery|January 22, 2017
Predictors of operative failure in parathyroidectomy for primary hyperparathyroidismDavid C Cron, Steven R Kapeles, Elizabeth A Andraska, et al.
Urology Practice|December 18, 2018
Potential Savings in Medicare Part D for Common Urological ConditionsPeter S Kirk, Tudor Borza, James M Dupree, et al.
BJU International|September 25, 2018
Characterising potential bone scan overuse amongst men treated with radical prostatectomyPeter S Kirk, Tudor Borza, Megan E V Caram, et al.
BJU International|July 18, 2019
Characterising 'bounce-back' readmissions after radical cystectomyPeter S Kirk, Ted A Skolarus, Bruce L Jacobs, et al.
Pageof 2